In this study, silencing of HOXD9 enhanced the expression of cleaved caspase-3 and cleaved PARP1 in NSCLC cells, identifying the anti-apoptotic function of HOXD9 in NSCLC. The gene discussed is PARP1; the disease is non-small cell lung carcinoma.